Loading clinical trials...
Loading clinical trials...
A Prospective, Longitudinal, Multinational, Observational Study to Describe Patterns of Care and Outcomes of Men Who Are at High Risk for Poor Clinical Outcomes After Experiencing Biochemical Failure Following Definitive Prostate Cancer Therapy, Men With Castration-Resistant Prostate Cancer and Men With Metastatic Prostate Cancer at Initial Diagnosis
The purpose of this study is to describe patterns in disease management and to describe clinical outcomes, as well as to identify factors influencing physician treatment decisions including reason(s) for treatment choices and trigger(s) for treatment changes and to document healthcare resource utilization used to manage treatment-related complications.
Each subject will be followed from the time of enrollment for a minimum of 3 years and a maximum of up to 6 years or until death, whichever comes first.
Age
All ages
Sex
MALE
Healthy Volunteers
No
Site
Algiers, Algeria
Site
Algiers, Algeria
Site
Blida, Algeria
Site
Buenos Aires, Argentina
Site
La Pampa, Argentina
Site
Paraje Cabal, Argentina
Site
Port Macquarie, New South Wales, Australia
Site
Tweed Heads, New South Wales, Australia
Site
Kurralta Park, South Australia, Australia
Site
Parkville, Victoria, Australia
Start Date
December 31, 2013
Primary Completion Date
November 14, 2019
Completion Date
November 14, 2019
Last Updated
December 20, 2019
1,533
ACTUAL participants
Lead Sponsor
Astellas Pharma Global Development, Inc.
NCT06842498
NCT05691465
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and ConditionsNCT04550494